1-13 of 13
Igor Aurer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bone Mineral Density in Hodgkin Lymphoma Patients Treated with Escalated Beacopp: Focus on Steroid Administration and Age-Related Effects

Ida Hude, Anja Tea Golubić, Sandra Bašić-Kinda, Antonela Lelas, Ida Ivek, Helena Markotić, Martina Morić Perić, Dino Dujmović, Ivo Radman, Barbara Dreta, Margareta Dobrenić, Snježana Dotlić, Ivana Ilić, Dražen Huić, Igor Aurer
Journal: Blood
Blood (2024) 144 (Supplement 1): 2337.
https://doi.org/10.1182/blood-2024-209649
Published: 2024
Journal Articles

Clinical Features and Treatment Outcomes of Grey Zone Lymphoma (GZL), Unclassifiable B-Cell Lymphoma with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma - a Real-Life Multicenter Study By the Croatian Cooperative Group for Hematologic Diseases (KroHem)

Ida Hude, Klara Brčić, Martina Morić Perić, Vibor Milunović, Milan Vujčić, Ivan Krecak, Zdravko Mitrović, Božena Coha, Slavko Gašparov, Snježana Dotlić, Ivana Ilić, Sandra Bašić-Kinda, Igor Aurer, Goran Rinčić
Journal: Blood
Blood (2023) 142 (Supplement 1): 7394.
https://doi.org/10.1182/blood-2023-187158
Published: 2023
Journal Articles

Serologic Responses Following Sars-Cov-2 Vaccination and Factors Influencing It in Patients with Hematological Malignant and Non-Malignant Diseases - a Prospective Multicentric Study

Zrinka Sertić, Marko Lucijanic, Sandra Bašić-Kinda, Ranka Serventi Seiwerth, Vlatka Periša, Dubravka Sertić, Bozena Coha, Drazen Pulanic, Dragana Šegulja, Dunja Rogić, Toni Valkovic, Igor Aurer, Nadira Durakovic
Journal: Blood
Blood (2021) 138 (Supplement 1): 47.
https://doi.org/10.1182/blood-2021-153573
Published: 2021
Journal Articles

Purine Analogues Increase the Risk of Lethal and/or Prolonged COVID19 While Obinutuzumab Increases the Risk of Prolonged but Not Lethal Infection in Patients Treated for Lymphoid Malignancies -a Study of Krohem, the Croatian Group for Hematologic Diseases

Igor Aurer, Ozren Jaksic, Sandra Bašić-Kinda, Stefan Mrdenovic, Slobodanka Ostojic Kolonic, Dominik Lozic, Hrvoje Holik, Sabina Novakovic Coha, Petra Bernes, Ivan Krecak, Martina Moric Peric, Marino Narancic, Zdravko Mitrovic, Toni Valkovic
Journal: Blood
Blood (2021) 138 (Supplement 1): 3553.
https://doi.org/10.1182/blood-2021-149613
Published: 2021
Journal Articles

A Randomized, Double-Blind Efficacy and Safety Study of PF-05280586 (a Potential Rituximab Biosimilar) Compared with Rituximab Reference Product (MabThera ® ) in Subjects with Previously Untreated CD20-Positive, Low Tumor Burden Follicular Lymphoma (LTB-FL)

Jeff Sharman, MD, Anna Marina Liberati, MD, Rodrigo Santucci Silva, MD, Igor Aurer, MD PhD, Jeffery Robbins, MS, Julie Ann Rosenberg, MD, Tahira Khan, MD MS, Ann Alcasid
Journal: Blood
Blood (2018) 132 (Supplement 1): 394.
https://doi.org/10.1182/blood-2018-99-111248
Published: 2018
Journal Articles

Risk of Histological Transformation in Patients with Primary Refractory Follicular Lymphoma

Sara Alonso, MD, Martina Manni, PhD, Clementine Sarkozy, MD, Marielle Wondergem, MD, Attilio Guarini, MD, Laura Magnano, MD, Miguel Alcoceba, PhD, Martine E.D. Chamuleau, MD, Sara Galimberti, Maria Gomes da Silva, MD, Harald Holte, MD PhD, Emanuele Zucca, MD, Silvia Montoto, MD, Sandra Lockmer, MD, Igor Aurer, MD PhD, Luigi Marcheselli, MSc, Dolores Caballero, MD, Gilles Salles, MD PhD, Massimo Federico, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4145.
https://doi.org/10.1182/blood-2018-99-115956
Published: 2018
Journal Articles

External Validation and Revision of Thrombosis Lymphoma /Throly/ Score

Darko Antic, PhD, Natasa Milic, Biljana Mihaljevic, Bruce Cheson, MD, Mayur Narkhede, MD, Hikmat Abdel-Razeq, Irina Panovska, Sanja Trajkova, Marija Popova, Igor Aurer, Ana Boban, Michele Ghielmini, Alden Moccia, Aurelien Delluc, Jean-Christophe Ianotto, Ulrich Jaeger, MD, Cathrin Skrabs, Grigorios T. Gerotziafas, Jawed Fareed, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 140.
https://doi.org/10.1182/blood-2018-99-115568
Published: 2018
Journal Articles

PET-Based Response after 2 Cycles of Brentuximab Vedotin in Combination with AVD for First-Line Treatment of Unfavorable Early-Stage Hodgkin Lymphoma: First Analysis of the Primary Endpoint of Breach, a Randomized Phase II Trial of Lysa-FIL-EORTC Intergroup

Luc-Matthieu Fornecker, Julien Lazarovici, MD, Igor Aurer, PhD, Rene-Olivier Casasnovas, MD, Anne-Claire Gac, Christophe Bonnet, MD PhD, Krimo Bouabdallah, MD, Aurore Perrot, MD, Lena Specht, Mohamed Touati, Jean Claude Eisenmann, Cecile Borel, MD, Aspasia Stamatoullas, MD, Emmanuelle Nicolas-Virelizier, MD, Laurent Pascal, Pieternella Lugtenburg, Monica Bellei, MSc, PhD, Alexandra traverse-Glehen, MD PhD, Christiane Copie, MDPhD, Martin Hutchings, MD PhD, Annibale Versari, Michel Meignan, Massimo Federico, Marc Andre, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 736.
https://doi.org/10.1182/blood.V130.Suppl_1.736.736
Published: 2017
Journal Articles

Extracellular Circulating DNA in Lymphoma Patients: Biological Correlates and Prognostic Impact

Dino Dujmovic, MD, Vedrana Skaro, Sandra Basic-Kinda, MD, Dora Markulin, Ivana Samarzija, Pavle Roncevic, MD, Ivo Radman, MD, Danijela Kolenc, MD PhD, Klara Dubravcic, Gordan Lauc, Igor Aurer, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5365.
https://doi.org/10.1182/blood.V124.21.5365.5365
Published: 2014
Journal Articles

Decision Driven Factors for Allopurinol Dosage in Tumor Lysis Syndrome Prophylaxis: The European Experience of the Florence Pivotal Study

Simone Baldini, MD, Cristina Rossi, PhD, Michele Spina, MD, Massimo Federico, MD, Zsolt Nagy, MD, Karin Jordan, MD PhD, Igor Aurer, MD PhD, Josep-Maria Ribera, MD PhD, Gabriela Borsaru, MD, Nataliia Glushko, MD, Sebastian Grosicki, MD, Alexander Pristupa, MD, Alberto Bosi, MD, Eduardo M. Rego, MD PhD, Andrea Nizzardo, PhD, Simona Scartoni, PhD, Alessandra Scordari, PhD, Mariagiuseppa Matera, PhD, Carlo Alberto Maggi, MD PhD, Angela Capriati, MD PhD, Cecilia Simonelli, MD
Journal: Blood
Blood (2014) 124 (21): 5979.
https://doi.org/10.1182/blood.V124.21.5979.5979
Published: 2014
Journal Articles

Dose-Intense BACOP for Treatment of High Risk Peripheral T-Cell NHL (PTCL)

Igor Aurer, MD, PhD, Dino Dujmovic, MD, Ivo Radman, MD, Sandra Basic-Kinda, MD, Damir Nemet, MD, PhD, Ivana Ilic, MD, PhD, Ranka Stern-Padovan, MD, PhD, Fedor Santek, MD, PhD, Dubravka Sertic, MD
Journal: Blood
Blood (2010) 116 (21): 4889.
https://doi.org/10.1182/blood.V116.21.4889.4889
Published: 2010
Journal Articles

Continuous High-Dose Chlorambucil in Previously Untreated Patients with Chronic Lymphocytic Leukemia –Single-Center Experience.

Sandra Basic-Kinda, Igor Aurer, Dino Dujmovic, Ivo Radman, Dubravka Sertic, Klara Dubravcic, Koraljka Gjadrov-Kuvezdic, Drago Batinic, Mirna Sucic, Boris Labar
Journal: Blood
Blood (2009) 114 (22): 2372.
https://doi.org/10.1182/blood.V114.22.2372.2372
Published: 2009
Journal Articles

Gem-(R)CHOP Versus (R)CHOP: A Randomized Phase II Study of Gemcitabine Combined with (R)CHOP in Untreated Aggressive Non- Hodgkin’s Lymphoma - EORTC Lymphoma Group Protocol 20021

Igor Aurer, Houchingue Eghbali, John M. Raemaekers, Hussein M Khaled, Martine Van Glabbeke, Liliana Baila, Richard van der Maazen
Journal: Blood
Blood (2008) 112 (11): 3609.
https://doi.org/10.1182/blood.V112.11.3609.3609
Published: 2008